Skip to main content

Hls Therapeutics Inc(HLS-T)

Today's Change
Real-Time Last Update

Hls Therapeutics Inc

10 Carlson Court
Suite 701
Etobicoke ON M9W6L2 CAN
P: 647-495-9000
F: 416-213-0045

Sectors & Indices



HLS Therapeutics Inc is a specialty pharmaceutical company. It is focused on the acquisition and commercialization of branded pharmaceutical products in the North American markets. The company products include Clozaril, Vascepa, Trinomia, and Perseris. The company earns revenue in the form of product sales and royalties, out of which product sales contribute to the majority of the revenue. The company operates in Canada, the United States, and the Rest of the world.

Key Executives

Jason GrossVice President, Divisional
Tim HendricksonCFO
Ryan C. LennoxSecretary/Senior VP, Divisional
Sanjiv SharmaOther Executive Officer
Craig Stuart MillianCEO/Director
Patricia PerryVice President, Divisional
David SpenceVice President, Divisional
Dawn EdinboroGeneral Manager, Subsidiary/Vice President